Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case

This report describes the laparoscopic resection of a rectal GIST after treatment with imatinib mesylate. A 56-year-old male presented with a submucosal tumor (longest diameter, 8 cm) arising in the lower rectum. A core needle biopsy revealed that the tumor contained bundles of spindle-like cells. I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery today (Tokyo, Japan) Japan), 2012-11, Vol.42 (11), p.1096-1099
Hauptverfasser: Nakamura, Takatoshi, Mitomi, Hiroyuki, Onozato, Wataru, Sato, Takeo, Ikeda, Atsushi, Naito, Masanori, Ogura, Naoto, Kamata, Hiroki, Ooki, Akira, Watanabe, Masahiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1099
container_issue 11
container_start_page 1096
container_title Surgery today (Tokyo, Japan)
container_volume 42
creator Nakamura, Takatoshi
Mitomi, Hiroyuki
Onozato, Wataru
Sato, Takeo
Ikeda, Atsushi
Naito, Masanori
Ogura, Naoto
Kamata, Hiroki
Ooki, Akira
Watanabe, Masahiko
description This report describes the laparoscopic resection of a rectal GIST after treatment with imatinib mesylate. A 56-year-old male presented with a submucosal tumor (longest diameter, 8 cm) arising in the lower rectum. A core needle biopsy revealed that the tumor contained bundles of spindle-like cells. Immunostaining revealed that the tumor was positive for c-kit and CD34. Analysis of the c-kit gene revealed a substitution of ACA (threonine) by GCA (alanine) at codon 574 of exon 11. Imatinib mesylate (400 mg/day) was given as preoperative adjuvant therapy for 3 months, and the tumor shrank to 5 cm in diameter. Proctectomy with transanal anastomosis could be performed laparoscopically, while preserving the anus. There was no evidence of recurrence 2 years 6 months after surgery. Preoperative adjuvant chemotherapy with imatinib mesylate may permit the use of less invasive treatment procedures, allowing anal preservation.
doi_str_mv 10.1007/s00595-012-0134-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1237505476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1237505476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-b8643dcf8511a547125b719037f26fad2d8e54fe2d1616c39ae06da4504022dd3</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq2qqCzQH9BL5SOX0BnH-eqtQrQgrdQLnC2vM9kNSuLUdoQ48s-ZVYBjD9bI8vO-1jxCfEO4QoDqRwQomiIDVHxyndWfxAZ1Xmaqxvyz2ECjMUPV4Kk4i_ERQOka4Is4VUo1Wiu9ES9bO9vgo_Nz72SgSC71fpK-k1bubUzB91OimPrJDvJ4HXmmZfThyKQDccjxXdouUZApkE0jTUk-9ekg-9Fyst_JkeLzYBP9ZHz2Ia0fOBvpQpx0doj09W2ei4ffN_fXt9n275-761_bzOVNlbJdXeq8dV1dINpCV6iKXYUN5FWnys62qq2p0B2pFkssOWMJytbqAjQo1bb5ubhce-fg_y28kRn76GgY7ER-iQZVXhXAzSWjuKKOzcRAnZkDbxKeDYI5mjerecPmzdG8qTnz_a1-2Y3UfiTeVTOgViDy07SnYB79Ethq_E_rK-KpkE0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237505476</pqid></control><display><type>article</type><title>Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Nakamura, Takatoshi ; Mitomi, Hiroyuki ; Onozato, Wataru ; Sato, Takeo ; Ikeda, Atsushi ; Naito, Masanori ; Ogura, Naoto ; Kamata, Hiroki ; Ooki, Akira ; Watanabe, Masahiko</creator><creatorcontrib>Nakamura, Takatoshi ; Mitomi, Hiroyuki ; Onozato, Wataru ; Sato, Takeo ; Ikeda, Atsushi ; Naito, Masanori ; Ogura, Naoto ; Kamata, Hiroki ; Ooki, Akira ; Watanabe, Masahiko</creatorcontrib><description>This report describes the laparoscopic resection of a rectal GIST after treatment with imatinib mesylate. A 56-year-old male presented with a submucosal tumor (longest diameter, 8 cm) arising in the lower rectum. A core needle biopsy revealed that the tumor contained bundles of spindle-like cells. Immunostaining revealed that the tumor was positive for c-kit and CD34. Analysis of the c-kit gene revealed a substitution of ACA (threonine) by GCA (alanine) at codon 574 of exon 11. Imatinib mesylate (400 mg/day) was given as preoperative adjuvant therapy for 3 months, and the tumor shrank to 5 cm in diameter. Proctectomy with transanal anastomosis could be performed laparoscopically, while preserving the anus. There was no evidence of recurrence 2 years 6 months after surgery. Preoperative adjuvant chemotherapy with imatinib mesylate may permit the use of less invasive treatment procedures, allowing anal preservation.</description><identifier>ISSN: 0941-1291</identifier><identifier>EISSN: 1436-2813</identifier><identifier>DOI: 10.1007/s00595-012-0134-8</identifier><identifier>PMID: 22294424</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Antineoplastic Agents - administration &amp; dosage ; Benzamides ; Biopsy, Fine-Needle ; Case Report ; Colectomy - methods ; Follow-Up Studies ; Gastrointestinal Stromal Tumors - drug therapy ; Gastrointestinal Stromal Tumors - pathology ; Gastrointestinal Stromal Tumors - surgery ; Humans ; Imatinib Mesylate ; Immunohistochemistry ; Laparoscopy - methods ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoadjuvant Therapy - methods ; Neoplasm Invasiveness - pathology ; Neoplasm Staging ; Piperazines - administration &amp; dosage ; Preoperative Care - methods ; Pyrimidines - administration &amp; dosage ; Rectal Neoplasms - drug therapy ; Rectal Neoplasms - pathology ; Rectal Neoplasms - surgery ; Risk Assessment ; Surgery ; Surgical Oncology ; Treatment Outcome</subject><ispartof>Surgery today (Tokyo, Japan), 2012-11, Vol.42 (11), p.1096-1099</ispartof><rights>Springer 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-b8643dcf8511a547125b719037f26fad2d8e54fe2d1616c39ae06da4504022dd3</citedby><cites>FETCH-LOGICAL-c397t-b8643dcf8511a547125b719037f26fad2d8e54fe2d1616c39ae06da4504022dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00595-012-0134-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00595-012-0134-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22294424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakamura, Takatoshi</creatorcontrib><creatorcontrib>Mitomi, Hiroyuki</creatorcontrib><creatorcontrib>Onozato, Wataru</creatorcontrib><creatorcontrib>Sato, Takeo</creatorcontrib><creatorcontrib>Ikeda, Atsushi</creatorcontrib><creatorcontrib>Naito, Masanori</creatorcontrib><creatorcontrib>Ogura, Naoto</creatorcontrib><creatorcontrib>Kamata, Hiroki</creatorcontrib><creatorcontrib>Ooki, Akira</creatorcontrib><creatorcontrib>Watanabe, Masahiko</creatorcontrib><title>Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case</title><title>Surgery today (Tokyo, Japan)</title><addtitle>Surg Today</addtitle><addtitle>Surg Today</addtitle><description>This report describes the laparoscopic resection of a rectal GIST after treatment with imatinib mesylate. A 56-year-old male presented with a submucosal tumor (longest diameter, 8 cm) arising in the lower rectum. A core needle biopsy revealed that the tumor contained bundles of spindle-like cells. Immunostaining revealed that the tumor was positive for c-kit and CD34. Analysis of the c-kit gene revealed a substitution of ACA (threonine) by GCA (alanine) at codon 574 of exon 11. Imatinib mesylate (400 mg/day) was given as preoperative adjuvant therapy for 3 months, and the tumor shrank to 5 cm in diameter. Proctectomy with transanal anastomosis could be performed laparoscopically, while preserving the anus. There was no evidence of recurrence 2 years 6 months after surgery. Preoperative adjuvant chemotherapy with imatinib mesylate may permit the use of less invasive treatment procedures, allowing anal preservation.</description><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Benzamides</subject><subject>Biopsy, Fine-Needle</subject><subject>Case Report</subject><subject>Colectomy - methods</subject><subject>Follow-Up Studies</subject><subject>Gastrointestinal Stromal Tumors - drug therapy</subject><subject>Gastrointestinal Stromal Tumors - pathology</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Immunohistochemistry</subject><subject>Laparoscopy - methods</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy - methods</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Staging</subject><subject>Piperazines - administration &amp; dosage</subject><subject>Preoperative Care - methods</subject><subject>Pyrimidines - administration &amp; dosage</subject><subject>Rectal Neoplasms - drug therapy</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectal Neoplasms - surgery</subject><subject>Risk Assessment</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Treatment Outcome</subject><issn>0941-1291</issn><issn>1436-2813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P3DAQhq2qqCzQH9BL5SOX0BnH-eqtQrQgrdQLnC2vM9kNSuLUdoQ48s-ZVYBjD9bI8vO-1jxCfEO4QoDqRwQomiIDVHxyndWfxAZ1Xmaqxvyz2ECjMUPV4Kk4i_ERQOka4Is4VUo1Wiu9ES9bO9vgo_Nz72SgSC71fpK-k1bubUzB91OimPrJDvJ4HXmmZfThyKQDccjxXdouUZApkE0jTUk-9ekg-9Fyst_JkeLzYBP9ZHz2Ia0fOBvpQpx0doj09W2ei4ffN_fXt9n275-761_bzOVNlbJdXeq8dV1dINpCV6iKXYUN5FWnys62qq2p0B2pFkssOWMJytbqAjQo1bb5ubhce-fg_y28kRn76GgY7ER-iQZVXhXAzSWjuKKOzcRAnZkDbxKeDYI5mjerecPmzdG8qTnz_a1-2Y3UfiTeVTOgViDy07SnYB79Ethq_E_rK-KpkE0</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Nakamura, Takatoshi</creator><creator>Mitomi, Hiroyuki</creator><creator>Onozato, Wataru</creator><creator>Sato, Takeo</creator><creator>Ikeda, Atsushi</creator><creator>Naito, Masanori</creator><creator>Ogura, Naoto</creator><creator>Kamata, Hiroki</creator><creator>Ooki, Akira</creator><creator>Watanabe, Masahiko</creator><general>Springer Japan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case</title><author>Nakamura, Takatoshi ; Mitomi, Hiroyuki ; Onozato, Wataru ; Sato, Takeo ; Ikeda, Atsushi ; Naito, Masanori ; Ogura, Naoto ; Kamata, Hiroki ; Ooki, Akira ; Watanabe, Masahiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-b8643dcf8511a547125b719037f26fad2d8e54fe2d1616c39ae06da4504022dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Benzamides</topic><topic>Biopsy, Fine-Needle</topic><topic>Case Report</topic><topic>Colectomy - methods</topic><topic>Follow-Up Studies</topic><topic>Gastrointestinal Stromal Tumors - drug therapy</topic><topic>Gastrointestinal Stromal Tumors - pathology</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Immunohistochemistry</topic><topic>Laparoscopy - methods</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy - methods</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Staging</topic><topic>Piperazines - administration &amp; dosage</topic><topic>Preoperative Care - methods</topic><topic>Pyrimidines - administration &amp; dosage</topic><topic>Rectal Neoplasms - drug therapy</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectal Neoplasms - surgery</topic><topic>Risk Assessment</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakamura, Takatoshi</creatorcontrib><creatorcontrib>Mitomi, Hiroyuki</creatorcontrib><creatorcontrib>Onozato, Wataru</creatorcontrib><creatorcontrib>Sato, Takeo</creatorcontrib><creatorcontrib>Ikeda, Atsushi</creatorcontrib><creatorcontrib>Naito, Masanori</creatorcontrib><creatorcontrib>Ogura, Naoto</creatorcontrib><creatorcontrib>Kamata, Hiroki</creatorcontrib><creatorcontrib>Ooki, Akira</creatorcontrib><creatorcontrib>Watanabe, Masahiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery today (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakamura, Takatoshi</au><au>Mitomi, Hiroyuki</au><au>Onozato, Wataru</au><au>Sato, Takeo</au><au>Ikeda, Atsushi</au><au>Naito, Masanori</au><au>Ogura, Naoto</au><au>Kamata, Hiroki</au><au>Ooki, Akira</au><au>Watanabe, Masahiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case</atitle><jtitle>Surgery today (Tokyo, Japan)</jtitle><stitle>Surg Today</stitle><addtitle>Surg Today</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>42</volume><issue>11</issue><spage>1096</spage><epage>1099</epage><pages>1096-1099</pages><issn>0941-1291</issn><eissn>1436-2813</eissn><abstract>This report describes the laparoscopic resection of a rectal GIST after treatment with imatinib mesylate. A 56-year-old male presented with a submucosal tumor (longest diameter, 8 cm) arising in the lower rectum. A core needle biopsy revealed that the tumor contained bundles of spindle-like cells. Immunostaining revealed that the tumor was positive for c-kit and CD34. Analysis of the c-kit gene revealed a substitution of ACA (threonine) by GCA (alanine) at codon 574 of exon 11. Imatinib mesylate (400 mg/day) was given as preoperative adjuvant therapy for 3 months, and the tumor shrank to 5 cm in diameter. Proctectomy with transanal anastomosis could be performed laparoscopically, while preserving the anus. There was no evidence of recurrence 2 years 6 months after surgery. Preoperative adjuvant chemotherapy with imatinib mesylate may permit the use of less invasive treatment procedures, allowing anal preservation.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>22294424</pmid><doi>10.1007/s00595-012-0134-8</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0941-1291
ispartof Surgery today (Tokyo, Japan), 2012-11, Vol.42 (11), p.1096-1099
issn 0941-1291
1436-2813
language eng
recordid cdi_proquest_miscellaneous_1237505476
source MEDLINE; SpringerLink Journals
subjects Antineoplastic Agents - administration & dosage
Benzamides
Biopsy, Fine-Needle
Case Report
Colectomy - methods
Follow-Up Studies
Gastrointestinal Stromal Tumors - drug therapy
Gastrointestinal Stromal Tumors - pathology
Gastrointestinal Stromal Tumors - surgery
Humans
Imatinib Mesylate
Immunohistochemistry
Laparoscopy - methods
Male
Medicine
Medicine & Public Health
Middle Aged
Neoadjuvant Therapy - methods
Neoplasm Invasiveness - pathology
Neoplasm Staging
Piperazines - administration & dosage
Preoperative Care - methods
Pyrimidines - administration & dosage
Rectal Neoplasms - drug therapy
Rectal Neoplasms - pathology
Rectal Neoplasms - surgery
Risk Assessment
Surgery
Surgical Oncology
Treatment Outcome
title Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T08%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20resection%20of%20a%20gastrointestinal%20stromal%20tumor%20of%20the%20rectum%20after%20treatment%20with%20imatinib%20mesylate:%20report%20of%20a%20case&rft.jtitle=Surgery%20today%20(Tokyo,%20Japan)&rft.au=Nakamura,%20Takatoshi&rft.date=2012-11-01&rft.volume=42&rft.issue=11&rft.spage=1096&rft.epage=1099&rft.pages=1096-1099&rft.issn=0941-1291&rft.eissn=1436-2813&rft_id=info:doi/10.1007/s00595-012-0134-8&rft_dat=%3Cproquest_cross%3E1237505476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237505476&rft_id=info:pmid/22294424&rfr_iscdi=true